Changes in Bone Quality after Treatment with Etelcalcetide.
Pascale KhairallahJenna CherasardJoshua SungSanchita AgarwalMaria Alejandra AponteMariana BucovskyMaria FusaroJeffrey SilberzweigGail N FrumkinKarim El HachemLinda SchulmanDonald McMahonMatthew R AllenCorinne E MetzgerRachel K SurowiecJoseph M WallaceThomas L NickolasPublished in: Clinical journal of the American Society of Nephrology : CJASN (2023)
Treatment with etelcalcetide for 36-weeks was associated with improvements in central skeleton areal bone mineral density and trabecular quality and lowered bone turnover without affecting bone material properties.